Andrew Cooper

机构：Tripler Army Medical Center · ORCID：0000-0003-1025-0268

发表论文 101 篇 · 总被引 3684 次 · h-index 30

代表论文

• Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER (2022 · BMC Endocrine Disorders · 被引 84)
• Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study (2021 · American Heart Journal · 被引 47)
• Impact of micro‐ and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study (2022 · Endocrinology Diabetes & Metabolism · 被引 38)
• Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study (2022 · Frontiers in Endocrinology · 被引 34)
• Social Needs Identified by Diagnostic Codes in Privately Insured U.S. Adults (2022 · American Journal of Preventive Medicine · 被引 15)
• Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study (2022 · Diabetes Research and Clinical Practice · 被引 9)